Organigram's balance sheet is robust with C$46.8 million in cash, no debt, and a healthy current ratio. See why I rate OGI ...

Amentum Holdings trades at a discount despite strong guidance and analyst optimism. Learn why AMTM stock could be a good ...

TransMedics is revolutionizing organ transplant therapy with its FDA-approved Organ Care System. See why I rate TMDX stock as ...

Occidental Petroleum’s market strength and Buffett's backing suggest strong growth. Learn why OXY stock remains an attractive ...

Ariel Mid Cap Value Composite delivered 0.00% gross of fees (-0.14% net of fees) for the quarter, outpacing the Russell Midcap Value Index’s -1.75% return. Read more here.

Texas Pacific Land returned 37% per year, beating the impressive 18% annual return of the Nasdaq Composite. See why I'm ...

Stay ahead this week with updates on Nvidia earnings, key inflation data, and GDP insights. Discover market trends and top ...

FSMD invests in small and mid-cap U.S. stocks with value, quality, momentum, and low volatility. Check out my recommendation for the fund.

Victoryshares Free Cash Flow ETF targets companies with high cash flow and growth. Learn why VFLO stock may underperform if ...

I screened for high-quality, competitively advantaged REITs to deliver 29% annualized returns in 2025. Check out my top 10 REITs for 2025.

Apollo Commercial Real Estate Finance's dividend cut in 3Q24 improved its dividend pay-out ratio. Read why I upgrade ARI from ...

Barings Corporate Investors has seen a sharp price increase, leading to a 35% premium. Learn why MCI stock may be overvalued ...